Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 31
- Next page
Title | Authors | Year | Journal | Link to Article | Intended Audience Sort descending | Purpose |
---|---|---|---|---|---|---|
Blood and clots quizlet 2: Trauma in a patient on warfarin | Shih A, Tseng E, de Wit K, Chan T | 2017 | CanadiEM website | View Blood and clots quizlet 2: Trauma in a patient on warfarin | Health care providers | Benchmarking and standard setting |
Donor selection, transmissible disease testing and pathogen reduction | Goldman M, Scalia V, Devine D | 2017 | Clinical Guide to Transfusion | View Donor selection, transmissible disease testing and pathogen reduction | Health care providers | Other |
Fractionated blood products and associated pathogen safety | Bigham M | 2017 | Clinical Guide to Transfusion | View Fractionated blood products and associated pathogen safety | Health care providers | Other |
Mechanisms of action and immunomodulation by IVIg | Khan R, Lazarus A | 2018 | Antibody Therapy: Substitution - Immunomodulation - Monoclonal Immunotherapy | View Mechanisms of action and immunomodulation by IVIg | Health care providers | Other |
Molecular immunohaematology round table discussions at the AABB Annual Meeting, Anaheim 2015 | Flegel WA, Castilho L, Heaton WA, Keller MA, Klapper EB, Lane WJ, Pirenne F, Shehata N, Stack G, St-Louis M, Tormey CA, Wagner FF, Waxman DA, Denomme GA | 2016 | Transfusion | View Molecular immunohaematology round table discussions at the AABB Annual Meeting, Anaheim 2015 | Health care providers | Clinical research |
Novel treatments for immune thrombocytopenia | Shih A, Nazi I, Kelton JG, Arnold DM | 2014 | Presse Med | View Novel treatments for immune thrombocytopenia | Health care providers | Clinical research |
Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis | Chugh S, Darvish-Kazem S, Lim W, Crowther MA, Ghanima W, Wang G, Heddle NM, Kelton JG, Arnold DM | 2015 | Lancet Haematol | View Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis | Health care providers | Clinical research |
The importance of haemophilia treatment centre administrators in patient care | Almonte T, Decker K, Seroski W, Walker I, Webert K, Bos C, Strike K, Waterhouse L, Goldsmith R, Chan AK | 2012 | Haemophilia | View The importance of haemophilia treatment centre administrators in patient care | Health care providers | Other |
The use of serial outpatient complete blood count (CBC) results to derive biologic variation: a new tool to gauge the acceptability of hematology testing | Cembrowski G, Topping K, Versluys K, Tran D, Malick M, Holmes D, Clarke G | 2015 | Int J Lab Hematol | View The use of serial outpatient complete blood count (CBC) results to derive biologic variation: a new tool to gauge the acceptability of hematology testing | Health care providers | New or improved product or process |
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion | Carson JL, Stanworth SJ, Roubinian N, Fergusson DA, Triulzi D, Doree C, Hebert PC | 2016 | Cochrane Database Syst Rev | View Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion | Health care providers | Clinical research |
Albumine | Clarke G, Yan M | 2018 | Guide de la pratique transfusionnelle | View Albumine | Health care providers | Other |
Bonnes pratiques en matière de transfusion de plaquettes | Romans R | 2019 | Blood.ca website | View Bonnes pratiques en matière de transfusion de plaquettes | Health care providers | Benchmarking and standard setting |
Educating the next frontier of transfusionists: a transfusion camp pilot program for nurse practitioners | Shih AW, Morrison D, Sekhon AS, Lin Y, Charge S, Chipperfield K, Beaveridge J | 2020 | Transfusion | View Educating the next frontier of transfusionists: a transfusion camp pilot program for nurse practitioners | Health care providers | Other |
Influenza increases invasive meningococcal disease risk in temperate countries | Salomon A, Berry I, Tuite AR, Drews S, Hatchette T, Jamieson F, Johnson C, Kwong J, Lina B, Lojo J, Mosnier A, Ng V, Vanhems P, Fisman DN | 2020 | Clin Microbiol Infect | View Influenza increases invasive meningococcal disease risk in temperate countries | Health care providers | Clinical research |
Platelet clinical best practices | Romans R | 2019 | Blood.ca website | View Platelet clinical best practices | Health care providers | Benchmarking and standard setting |
Surveillance Report 2018 | O'Brien S | 2019 | Blood.ca website | View Surveillance Report 2018 | Health care providers | Benchmarking and standard setting |
COVID-19 versus HIT hypercoagulability | Warkentin TE, Kaatz S | 2020 | Thromb Res | View COVID-19 versus HIT hypercoagulability | Health care providers | Clinical research |
Vox Sanguinis International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Summary | Goldman M, Townsend M, Magnussen K, Lozano M, Nissen-Meyer LS, Lee CK, Leung JN, Takanashi M, McKay J, Kvist M, Robitaille N, Deschênes J, Di Angelantonio E, McMahon A, Roberts D, Maghsudlu M, Castrén J, Tiberghien P, Woimant G, Morel P, Kamel H, Bravo M, Shinhar E, Gendelman V, Raz H, Wendel S, Fachini R, Quee F, van den Hurk K, Wiersum J, Grima K, Speedy J, Bruun M, Dunbar N | 2021 | Vox Sang | View Vox Sanguinis International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Summary | Health care providers | Benchmarking and standard setting |
ResearchUnit: Convalescent plasma is an ineffective treatment for patients with COVID-19 | Modi D | 2021 | Blood.ca website | View ResearchUnit: Convalescent plasma is an ineffective treatment for patients with COVID-19 | Health care providers | Clinical research |
Pathogen-reduced buffy coat platelets | Blais-Normandin I, Tordon B, Anani W | 2022 | Blood.ca website | View Pathogen-reduced buffy coat platelets | Health care providers | Benchmarking and standard setting |
Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility | Al-Riyami AZ, Estcourt L, Rahimi-Levene N, Bloch EM, Goel R, Tiberghien P, Thibert J-B, Bruun MT, Devine DV, Gammon RR, Wendel S, Toungouz Nevessignsky M, Grubovic Rastvorceva RM, Oreh A, Romon I, van den Berg K, Kitazawa J, Patidar G, So-Osman C, Wood EM, the ISBT COVID-19 Convalescent Plasma Working Group | 2022 | Vox Sang | View Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility | Health care providers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis | Jevtic SD, Arnold DM, Modi D, Ivetic N, Bissola AL, Nazy I | 2022 | Front Cardiovasc Med | View Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis | Health care providers | Clinical research |
Accuracy of International Classification of Diseases, 10th Revision Codes for Identifying Sepsis: A Systematic Review and Meta-Analysis | Liu B, Hadzi-Tosev M, Liu Y, Lucier KJ, Garg A, Li S, Heddle NM, Rochwerg B, Ning S | 2022 | Crit Care Explor | View Accuracy of International Classification of Diseases, 10th Revision Codes for Identifying Sepsis: A Systematic Review and Meta-Analysis | Health care providers | Clinical research |
A Primer on Biostatistics | Shih AW, Li N, Montemayor C, Heddle NM | 2022 | Practical Transfusion Medicine | View A Primer on Biostatistics | Health care providers | Benchmarking and standard setting |
A 13-question approach to resolving serological discrepancies in the transfusion medicine laboratory | Yudin J, Heddle NM | 2014 | Lab Med | View A 13-question approach to resolving serological discrepancies in the transfusion medicine laboratory | Health care providers | Clinical research |
Age of transfused blood in critically ill adults | Lacroix J, Hebert PC, Fergusson DA, Tinmouth A, Cook DJ, Marshall JC, Clayton L, McIntyre L, Callum J, Turgeon AF, Blajchman MA, Walsh TS, Stanworth SJ, Campbell H, Capellier G, Tiberghien P, Bardiaux L, van de Watering L, van der Meer NJ, Sabri E, Vo D | 2015 | N Engl J Med | View Age of transfused blood in critically ill adults | Health care providers | Clinical research |
Back to Anatomy: Improving Landmarking Accuracy of Clinical Procedures Using a Novel Approach to Procedural Teaching | Zeller M, Cristancho S, Mangel J, Goldszmidt M | 2015 | South Med J | View Back to Anatomy: Improving Landmarking Accuracy of Clinical Procedures Using a Novel Approach to Procedural Teaching | Health care providers | Other |
Blood donation and testosterone replacement therapy | Chin-Yee B, Lazo-Langner A, Butler-Foster T, Hsia C, Chin-Yee I | 2017 | Transfusion | View Blood donation and testosterone replacement therapy | Health care providers | Clinical research |
Changing trends in blood transfusion: an analysis of 244,013 hospitalizations | Shehata N, Forster A, Lawrence N, Rothwell DM, Fergusson D, Tinmouth A, Wilson K | 2014 | Transfusion | View Changing trends in blood transfusion: an analysis of 244,013 hospitalizations | Health care providers | Clinical research |
Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review | Warkentin TE, Pai M, Linkins LA | 2017 | Blood | View Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review | Health care providers | Clinical research |
Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data | Knoll GA, Kokolo MB, Mallick R, Beck A, Buenaventura CD, Ducharme R, Barsoum R, Bernasconi C, Blydt-Hansen TD, Ekberg H, Felipe CR, Firth J, Gallon L, Gelens M, Glotz D, Gossmann J, Guba M, Morsy AA, Salgo R, Scheuermann EH, Tedesco-Silva H, Vitko S, Watson C, Fergusson DA | 2014 | BMJ | View Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data | Health care providers | Clinical research |
Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH | Iorio A, Blanchette V, Blatny J, Collins P, Fischer K, Neufeld E | 2017 | J Thromb Haemost | View Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH | Health care providers | Clinical research |
Gestational hypertension and preeclampsia in living kidney donors | Garg AX, Nevis IF, McArthur E, Sontrop JM, Koval JJ, Lam NN, Hildebrand AM, Reese PP, Storsley L, Gill JS, Segev DL, Habbous S, Bugeja A, Knoll GA, Dipchand C, Monroy-Cuadros M, Lentine KL | 2015 | N Engl J Med | View Gestational hypertension and preeclampsia in living kidney donors | Health care providers | Clinical research |
Pitfalls in the diagnosis of heparin-induced thrombocytopenia: A 6-year experience from a reference laboratory | Nazi I, Arnold DM, Moore JC, Smith JW, Ivetic N, Horsewood P, Warkentin TE, Kelton JG | 2015 | Am J Hematol | View Pitfalls in the diagnosis of heparin-induced thrombocytopenia: A 6-year experience from a reference laboratory | Health care providers | Clinical research |
Red Blood Cell Storage Lesions and Related Transfusion Issues: A Canadian Blood Services Research and Development Symposium | Pavenski K, Saidenberg E, Lavoie M, Tokessy M, Branch DR | 2012 | Transfus Med Rev | View Red Blood Cell Storage Lesions and Related Transfusion Issues: A Canadian Blood Services Research and Development Symposium | Health care providers | Other |
Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support | Estcourt LJ, Malouf R, Trivella M, Fergusson DA, Hopewell S, Murphy MF | 2017 | Cochrane Database Syst Rev | View Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support | Health care providers | Clinical research |
Serological best practices: Anti-M | Clarke G, Cote J, Lane D | 2017 | Blood.ca website | View Serological best practices: Anti-M | Health care providers | Benchmarking and standard setting |
Supernatant reduction of stored gamma?irradiated red blood cells minimizes potentially harmful substances present in transfusion aliquots for neonates | Serrano K, Pambrun C, Levin E, Devine DV | 2017 | Transfusion | View Supernatant reduction of stored gamma?irradiated red blood cells minimizes potentially harmful substances present in transfusion aliquots for neonates | Health care providers | New or improved product or process |
Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. A meta-analysis | Chai-Adisaksopha C, Hillis C, Monreal M, Witt DM, Crowther M | 2015 | Thromb Haemost | View Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. A meta-analysis | Health care providers | Clinical research |
Triplets with neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1a | Solh Z, Breakey V, Murthy P, Smith JW, Arnold DM | 2016 | Transfusion | View Triplets with neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1a | Health care providers | Clinical research |
Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Jenkins C | 2018 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Health care providers | Benchmarking and standard setting |
Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls | Mannucci PM, Nobili A, Marchesini E, Oliovecchio E, Cortesi L, Coppola A, Santagostino E, Radossi P, Castaman G, Valdrè L, Santoro C, Tagliaferri A, Ettorre C, Zanon E, Barillari G, Cantori I, Caimi TM, Sottilotta G, Peyvandi F, Iorio A | 2018 | Haemophilia | View Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls | Health care providers | Clinical research |
Anti-Lewis | Peng S, Meunier D | 2019 | Blood.ca website | View Anti-Lewis | Health care providers | Clinical research |
Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents | Xu XR, Yousef GM, Ni H | 2018 | Blood | View Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents | Health care providers | Clinical research |
Laboratory diagnosis of heparin-induced thrombocytopenia | Warkentin TE | 2019 | Int J Lab Hematol | View Laboratory diagnosis of heparin-induced thrombocytopenia | Health care providers | Clinical research |
Système Rhésus : l’anticorps anti-V | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Rhésus : l’anticorps anti-V | Health care providers | Benchmarking and standard setting |
Development and Evaluation of a Whiteboard Video Series to Support the Education and Recruitment of Committed Unrelated Donors for Hematopoietic Stem Cell Transplantation | Li EW, Lee A, Vaseghi-Shanjani M, Anagnostopoulos A, Jagelaviciute G, Kum E, Petraszko T, Elmoazzen H, Allan D, Fingrut W | 2020 | Biol Blood Marrow Transplant | View Development and Evaluation of a Whiteboard Video Series to Support the Education and Recruitment of Committed Unrelated Donors for Hematopoietic Stem Cell Transplantation | Health care providers | New or improved product or process |
Filariasis and transfusion-associated risk: a literature review | Drews SJ, Spencer BR, Wendel S, Bloch EM, International Society of Blood Transfusion TTID Working Party Parasite Subgroup | 2021 | Vox Sang | View Filariasis and transfusion-associated risk: a literature review | Health care providers | Clinical research |
Research Unit: A more accurate and efficient way to manage blood demand and supply | Li N | 2021 | Blood.ca website | View Research Unit: A more accurate and efficient way to manage blood demand and supply | Health care providers | New or improved product or process |
Heparin or nonheparin anticoagulants for VITT | Arnold DM | 2022 | Blood | View Heparin or nonheparin anticoagulants for VITT | Health care providers | Clinical research |